Lauren Strosnick

Associate
lstrosnick@cooley.com
Full contact info

I love the challenge of distilling complex technology to tell my client’s story in the most compelling way.

About Lauren

Lauren’s practice focuses on intellectual property litigation with an emphasis on patent litigation. She handles cases spanning a broad range of technologies, including antibody therapeutics, pharmaceutical formulations, computer software, user interface design and video surveillance systems.

View full bio

Passions

Hiking, art, fiction writing

Experience

Sight Sciences Announces Successful Patent Infringement Verdict

Sight Sciences Announces Successful Patent Infringement Verdict

April 26, 2024

Cooley represented Sight Sciences (listed as SGHT on Nasdaq), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, which received a jury trial win on April 26, 2024, against its competitors – Alcon, Alcon Vision and Alcon Research (collectively known as Alcon) and Ivantis – in the US District Court for the District of Delaware.

Read more

Related contacts

Dr. Michelle Rhyu
Partner, Palo Alto
Orion Armon
Partner, Colorado
Jeffrey Karr
Of Counsel, Palo Alto
Eamonn Gardner
Partner, Colorado
Joseph Van Tassel
Associate, Reston
Alissa Wood
Associate, Palo Alto
Lauren Strosnick
Associate, Palo Alto
Bonnie Fletcher Price
Associate, Washington, DC
Juan Pablo González
Associate, Palo Alto
Angela Madrigal
Associate, Palo Alto
Jeannine Douglas
Paralegal Specialist, Palo Alto
Kelly Murata
Paralegal Specialist, San Francisco
Dustin Knight
Associate, Washington, DC

Related Practices & Industries

Medtech
Intellectual Property
Intellectual Property Litigation
Life Sciences IP Litigation
Patent Counseling and Prosecution – Life Sciences
Patent Office Litigation

Cooley Secures Win for Liquidia to Launch First Product

Cooley Secures Win for Liquidia to Launch First Product

April 5, 2024

Cooley successfully lifted a Hatch-Waxman injunction for Liquidia Technologies, a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products, enabling Liquidia to launch its new drug, Yutrepia.

Read more

Related contacts

Sanya Sukduang
Partner, Washington, DC
Jonathan Davies
Partner, Washington, DC
Ivor Elrifi
Partner, New York
Daniel Knauss
Partner, Palo Alto
Adam Pivovar
Partner, Washington, DC
Brittany Cazakoff
Associate, Washington, DC
Robert Minn
Associate, Palo Alto
Lauren Strosnick
Associate, Palo Alto
Jennifer Volk-Fortier
Associate, Washington, DC
Sam Whitt
Associate, Washington, DC
Larissa Diaz
Senior Paralegal, Washington, DC
Jeannine Douglas
Paralegal Specialist, Palo Alto
Melissa Eskola
Paralegal Specialist, Reston
Loreylys Feliciano
Paralegal Specialist, Chicago
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Hatch-Waxman Litigation
Patent Office Litigation
Intellectual Property
Intellectual Property Litigation
Life Sciences IP Litigation
Life Sciences

Admissions & credentials

California

Registered to practice before the United States Patent and Trademark Office (USPTO)

Memberships & affiliations

State Bar of California

Chiefs in Intellectual Property (ChIPs)